LAKE FOREST, CA--(MARKET WIRE)--Apr 17, 2008 -- CryoPort, Inc. (OTC BB:CYRX.OB - News) today announced that it has made an initial shipment of clinical samples on behalf of Quest Diagnostics.

This shipment was comprised of clinical samples that were shipped internationally. Federal Express handled all shipping segments.

Peter Berry, CEO of CryoPort, commented, "The CryoPort Express(TM) Shipper performed perfectly keeping the samples frozen and safe. We anticipate handling other shipments for diagnostic laboratories as we build out our logistics platform both in the US and Europe."

Peter Berry continued, "With every shipment we are learning and building our platform to serve the needs of our clients. While this process is continuing we are working very diligently at adding new potential customers to our roster of initial users."

To be added to the CryoPort Investor email list, please email edward@carpedminc.com with CYRX in the subject line.

About CryoPort, Inc.

CryoPort (www.cryoport.com) develops leading edge, proprietary, technology-driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the testing, research and end user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment.

"SAFE HARBOR"

This press release contains forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

     Contact:
     Stuart Fine
     Carpe DM, Inc.
     908-469-1788
     stuart@carpedminc.com